Using miRNA-gene co-expression networks to predict abnormal gap junctional communication in anthracycline-treated cardiomyocytes

A network prediction, cardiomyocyte technology, applied in the field of miRNA-gene co-expression network, can solve problems such as heart damage

Active Publication Date: 2021-06-15
JINZHOU MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Both clinical research and practical observation have shown that the cardiotoxicity caused by anthracyclines is often progressive and irreversible, especially the initial use of anthracyclines may cause heart damage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037] Gap junction (Gap junction, GJ), also known as gap leveling or between smooth muscle and nerve cells, can transmit electrical impulses through this. Structural and functional integrity of gap junctions in synchronous contraction of myocardium. Cardiomyocytes transmit ions, small molecular metabolites and secondary messengers through gap junctions, providing a low-resistance conduction path between cardiomyocytes, and their activities are coordinated. Due to the different types, sizes, and distribution patterns of gap junctions on the cell surface, the biological and physical characteristics of the connecting channels between cells are also different, which is manifested as the difference in impedance between cells, and the propagation of excitement is discontinuous. Under pathological conditions, the expression and function of gap junction genes will change, resulting in altered electrical activity between cells. The technical solution disclosed by the invention is hel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for predicting anthracycline drug cardiomyocyte gap junction communication abnormality using miRNA-gene co-expression network, comprising the following steps: Step 1: Experimental grouping; Step 2: RNA extraction; Step 3: miRNA-gene chip data Differential expression analysis; step 4: miRNA target gene analysis and regulatory network construction. The present invention uses the miRNA-gene co-expression network to predict the abnormality of anthracycline drug cardiomyocyte gap junction communication, and predicts the abnormal cardiomyocyte gap junction communication through the miRNA-gene co-expression network, which is a new molecular marker for discovering anthracycline drug cardiotoxicity A new approach is provided, which provides a reference for predicting its prognosis.

Description

technical field [0001] The invention relates to a miRNA-gene co-expression network, in particular to a method for predicting anthracycline drug cardiomyocyte gap junction communication abnormality by using the miRNA-gene co-expression network. Background technique [0002] Anthracyclines, including Doxorubicin (DOX), Epirubicin (EPI) and Pirarubicin (THP), are widely used in the treatment of hematological malignancies and solid tumors, such as breast Cancer, lymphoma, acute leukemia, etc. Combination therapy based on anthracyclines is usually the standard first-line treatment, with definite curative effect and indispensable, but it can cause toxic and side effects such as hair loss, bone marrow suppression and cardiotoxicity. Cardiotoxicity (Anthracycline Induced Cardiotoxicity, AIC) is the most serious side effect of anthracyclines. Van et al. used Meta-analysis to show that coenzyme Q10, levocarnitine, N-acetylcysteine, VC and VE had no obvious cardioprotective effect on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): G16C20/30G16C20/50G16C20/80G16C20/70
Inventor 王亚帝何东宁陈素贤陈书睿林琳
Owner JINZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap